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ABSTRACT

ARTICLE HISTORY

Introduction: A number of arboviruses have previously been isolated from naturally-infected
East African bats, however the role of bats in arbovirus maintenance is poorly understood.
The aim of this study was to investigate the exposure history of Ugandan bats to a panel of
arboviruses.
Materials and methods: Insectivorous and fruit bats were captured from multiple locations
throughout Uganda during 2009 and 2011–2013. All serum samples were tested for neutralizing antibodies against West Nile virus (WNV), yellow fever virus (YFV), dengue 2 virus
(DENV-2), Zika virus (ZIKV), Babanki virus (BBKV), and Rift Valley fever virus (RVFV) by plaque
reduction neutralization test (PRNT). Sera from up to 626 bats were screened for antibodies
against each virus.
Results and Discussion: Key findings include the presence of neutralizing antibodies against
RVFV in 5/52 (9.6%) of little epauletted fruit bats (Epomophorus labiatus) captured from
Kawuku and 3/54 (5.6%) Egyptian rousette bats from Kasokero cave. Antibodies reactive to
flaviviruses were widespread across bat taxa and sampling locations.
Conclusion: The data presented demonstrate the widespread exposure of bats in Uganda to
arboviruses, and highlight particular virus-bat associations that warrant further investigation.
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Introduction
Uganda has a rich history in arbovirology field and
laboratory studies beginning in the early 1930’s at the
Rockefeller Foundation’s Yellow Fever Research Institute
(currently known as the Uganda Virus Research Institute
(UVRI)). Notably, researchers at the UVRI are credited
with the isolation and discovery of over 20 novel arboviruses from the country including Semliki Forest (SFV),
West Nile (WNV), o’nyong-nyong (ONNV),
Bunyamwera (BUNV), Bwamba (BWAV), and Zika
viruses (ZIKV) [1], as well as the elucidation of the
sylvatic transmission cycles for both yellow fever virus
(YFV) and ZIKV in Uganda [2–4]. Among the virus
ecology studies focused on vertebrate reservoirs, research
at UVRI included investigations on bats for the purposes
of virus discovery [5,6], surveillance [7,8], and evaluation
of pathogenicity and infectivity of potential vertebrate
hosts to arthropods [9]. These valuable studies demonstrated a widespread seroprevalence of arboviruses
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among Ugandan bats [7,8]. However, interpretation of
these serological data is challenging due to the crossreactivity of flavivirus antibodies, providing incomplete
field evidence for a potential role of bats in the transmission cycles of particular arboviruses.
During 2008–2010, the CDC Division of Vectorborne Diseases (CDC/DVBD) re-initiated arbovirus surveillance activities in collaboration with UVRI [10].
During these investigations, the sources of a number of
blood meals identified from mosquitoes included fruit
bats. These mosquito-bat contacts were documented
from Maramagambo Forest in Queen Elizabeth
National Park, and Semliki Forest in Western Uganda
[11]. Additionally, the particular mosquito species which
had engorged on fruit bats are known to be associated
with a number of medically-important arboviruses:
Coquillettidia (Cq.) fuscopennata (Theobald) (YFV,
Sindbis, chikungunya viruses), Culex (Cx.) perfuscus
Edwards (WNV, Oropouche, Sindbis, Wesselsbron,
Usutu, Babanki viruses), Cx. (Cx.) neavei Theobald
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(WNV, Babanki, Spondweni, Sindbis, Koutango viruses),
and Cx. (Cx.) decens group (WNV, chikungunya,
Babanki viruses)[10]. Considering this evidence for exposure of bats to bites from mosquitoes associated with
arboviruses, an investigation to evaluate the seroprevalence of Ugandan bats to a panel of arboviruses was
undertaken. The purpose of this study was to follow-up
on earlier field investigations which reported high seroprevalence of known arboviruses, particularly flaviviruses
[7,8] in bats. Our goal was to identify bat-virus associations that would warrant further study for their potential
ecological significance for a role of bats in arbovirus
transmission and maintenance.

All bat captures were conducted under the approval of
IACUC protocols 1731AMMULX (Maramagambo
samples) and 010–015 (all other samples). Bats were
captured using harp traps or mist nets, and upon capture, placed individually in holding bags. Blood from
bats captured in Maramagambo forest was collected as
described by Towner et al. [12]. All other bats were
anesthetized with halothane and bled by cardiac puncture, then euthanized by halothane overdose and cervical dislocation. Blood from bats captured in locations
other than Maramagambo forest was collected directly
into serum separator tubes and centrifuged in the field,
and placed immediately in liquid nitrogen dry shippers.

Materials and methods

Serological testing

Sample collection
Bats were captured from multiple locations throughout Uganda during 2011–2013 (Table 1, Figure 1).
Additional samples collected from Egyptian rousette
bats captured previously at Maramagambo Forest in
2009 were provided for inclusion in this serosurvey.

All serum samples were frozen at −80°C until they
were tested for neutralizing antibodies against flaviviruses (Flaviviridae: Flavivirus): WNV, YFV, Dengue
virus type 2 (DENV-2), ZIKV; Babanki virus (BBKV)
(Togaviridae: Alphavirus), and Rift Valley fever virus
(RVFV) (Phenuiviridae: Phlebovirus) by plaque

Table 1. Species and sampling locations for bat sera tested, Uganda 2009, and 2011–2013.
Species

Common name

Chaerephon pumilus

Little free-tailed bat

Hipposideros ruber
Mops condylurus

Noack’s leaf-nosed bat
Angolan free-tailed bat

Nycteris macrotis
Eidolon helvum

Large-eared slit-faced bat
African straw-colored fruit-bat

Epomophorus labiatus

Little epauletted fruit bat

Lissonycteris angolensis
Rousettus aegyptiacus

Angolan soft-furred fruit bat
Egyptian rousette bat

Location

Collection date

Latitude

Longitude

Zika forest
Banga Nakiwogo
Kisubi
Kawuku
Kapkwai cave
Zika forest
Banga, Nakiwogo
Kaptum cave
Bugonga
Jinja
Kikaaya
Buwaya Lugonjo
Kasange
Kawuku
Kapkwai cave
Maramagambo
Tutum cave
Kasokero cave

Jun-11
Feb-12
Jan-13
Jan-13
Feb-12
Jun-11
Jun-11
Feb-12
Jun-11
Feb-12
Jun-11
Jun-2011, Feb-2012
Jun-11
Jan-13
Feb-12
Nov-09
Feb-12
Jan-13

0.11667
0.08333
0.11826
0.13487
1.33333
0.11667
0.08333
1.33333
0.05000
0.41667
0.37017
0.08333
0.15000
0.13487
1.33333
−0.26667
1.28333
−0.34214

32.53333
32.45000
32.53017
32.53392
34.41667
32.53333
32.45000
34.38333
32.46667
33.20000
32.58932
32.43333
32.40000
32.53392
34.41667
30.05000
34.46667
31.96627

Figure 1. Sampling locations for bats, 2009 – 2013. Capture locations for all bats tested in this study.
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reduction neutralization test (PRNT) [13]. While all
four dengue serotypes circulate in Africa, we chose to
screen samples for DENV-2 due to the frequent involvement of this serotype in epidemics in Africa [14].
Twofold serial dilutions of serum were incubated with
100 plaque-forming units (PFU) of WNV (strain
UG2274, Uganda), DENV-2 (strain DakHD10674,
Senegal), YFV (strain BA-55, Nigeria), ZIKV
(MP766, Uganda), BBKV (46A-186), and RVFV
(MP-12). A cutoff of ≥80% reduction in PFU on
Vero cells was selected. For flaviviruses, bats with an
antibody titer (PRNT80) at least four-fold higher than
the other flaviviruses were considered positive for antibody to that virus. Due to the serologic cross-reactivity
observed among the flaviviruses, bats with neutralizing
antibody titers against multiple flaviviruses for which
no fourfold difference in titer was observed or with
weak titers PRNT80 ≤ 20, where no four-fold difference could be observed, were considered flavivirus
antibody positive with no specific virus identified.
For some samples which returned ambiguous flavivirus results, we attempted to detect residual flavivirus
RNA from tissue samples collected from those bats in
order to positively identify the infecting virus. For
these samples, RNA from liver/spleen homogenates
was screened using pan-flavivirus primers [15]. For
BBKV and RVFV, serum samples with a titer of
PRNT80 ≥ 20 were considered seropositive. Because
of limited serum volumes, not enough serum was
available to test all bats for every virus, so some samples were not tested on the entire panel.
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Results
This study reports the results of serological testing
conducted on 626 bats captured in Uganda: 323 bats
captured from 2011 to 2013, and an additional 303
samples from Egyptian rousette bats sampled during
2009. Neutralizing antibodies against flaviviruses
were common. Significant neutralizing antibody titers
against WNV were found in 2/8 (25%) African strawcolored fruit bats sampled in Jinja in 2012, as well as
in 2/25 (8%) little epauletted fruit bats sampled in
Kikaaya and 1/19 (5.3%) from Buwaya Lugonjo
(Tables 2 and 3). One of 45 (2.2%) Egyptian rousette
bats sampled from Tutum cave had a neutralizing
antibody titer against YFV (Tables 2 and 3). One of
two little free-tailed bats (50%) and 1/2 (50%)
Angolan free-tailed bats sampled from Zika forest in
2011 contained specific antibodies against DENV-2
virus, as well as the single little epauletted fruit bat
from Buwaya Lugonjo that same year (Tables 2 and
3). However, 85/626 (13.5%) of bats possessed neutralizing antibodies against an undetermined flavivirus for which a 4-fold difference in antibody titer
was not observed for any one of the flaviviruses
included in the panel (Tables 2 and 3). Among
these bats, all 15/64 of the flavivirus antibody-positive
little free-tailed bats captured from Kawuku in 2013
reacted only to DENV-2, however at titers that were
not distinguishable from other flaviviruses based on
our criteria. Table 3 presents the endpoint antibody
titer of five representative bats for which a specific

Table 2. Prevalence of neutralizing antibodies detected in Ugandan bats, 2009 – 2013. Number positive/number tested for each
virus in each location and year.
Seroprevalence (PRNT80)

Common name

N

Year

Location

WNV

YFV

DENV-2

ZIKAV

Flavivirus
nonspecific

BBKV

Alphavirus
nonspecific

Little free-tailed
bat

2
15
5
64
3

2011
2012
2013
2013
2012

Zika forest
Banga Nakiwogo
Kisubi
Kawuku
Kapkwai cave

0/2
0/15
0/5
0/64
0/3

0/2
0/15
0/5
0/64
0/3

1/2
0/15
0/5
0/64
0/3

0/2
0/12
0/5
0/64
0/3

0/2
5/15
2/5
15/64*
1/3

0/2
0/14
0/5
0/64
0/3

0/2
0/14
0/5
0/64
0/3

0/2
0/15
0/5
0/64
0/3

2
32
10

2011
2011
2012

Zika forest
Banga, Nakiwogo
Kaptum cave

0/2
0/32
0/10

0/2
0/31
0/10

1/2
0/32
1/10

ND
ND
0/7

0/2
1/32
4/10

0/2
0/32
0/8

0/2
0/32
0/8

0/1
0/31
0/7

7
8

2011
2012

Bugonga
Jinja

0/7
2/8

0/7
0/8

0/7
0/8

ND
0/8

0/7
1/8

0/7
0/8

0/7
0/8

0/7
0/8

25
1
19
4
52
9

2011
2011
2012
2011
2013
2012

Kikaaya
Buwaya Lugonjo
Buwaya Lugonjo
Kasange
Kawuku
Kapkwai cave

2/25
0/1
1/19
0/4
0/52
0/9

0/25
0/1
0/19
0/4
0/52
0/9

0/25
1/1
0/19
0/4
0/52
0/9

ND
0/1
0/19
ND
0/52
0/9

0/25
0/1
0/19
1/4
3/52
0/9

1/25
0/1
0/19
0/4
0/52
0/9

0/25
0/1
0/19
0/4
0/52
0/9

0/25
0/1
0/19
0/4
5/52
0/9

303
45
54
626

2009
2012
2013

Maramagambo
Tutum cave
Kasokero cave

0/303
0/45
0/54
5/626

0/303
1/45
0/54
1/625

0/303
0/45
0/54
3/626

0/8
0/45
0/54
0/292

34/303
13/45
5/54
85/626

0/112
0/45
1/54
2/432

9/303
0/45
0/54
9/626

ND
0/45
3/54
8/318

Noack’s leafnosed bat
Angolan freetailed bat
Large-eared Slitfaced Bat
African Strawcolored Fruitbat
Little Epauletted
Fruit Bat

Angolan softfurred fruit bat
Egyptian rousette
TOTAL

*All 15 seropositive bats had low antibody reactive to DENV-2.
ND = not done.

RVFV
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Table 3. Example end-point titers of arbovirus neutralizing antibodies (PRNT80). The top five lines represent bats for which a
specific result was determined; the bottom five lines represent bats for which serological results were inconclusive.
PRNT80 endpoint titer
Bat #
1
96

Common Name
Little epauletted fruit bat
Little epauletted fruit bat

210
228
472

African straw-colored fruit
bat
Egyptian rousette bat
Egyptian rousette bat

98
173

Little epauletted fruit bat
Little free-tailed bat

175

Little free-tailed bat

236
247

Egyptian rousette bat
Egyptian rousette bat

DENV2
ZIKAV YFV RVFV
Result reported
<10
ND <10 <10 BBKV positive
40
ND <10 <10 DENV-2 positive

Site
Kikaaya
Buwaya
Lugonjo
Jinja

Date BBKV WNV
2011 80
<10
2011 <10 <10
2012 <10 >320

<10

<10

20

Tutum cave
Kasokero cave

2012 <10
2013 <20

<10
<20

20
20

<10
<20

Kasange
Banga
Nakiwogo
Banga
Nakiwogo
Tutum cave
Tutum cave

2011 <10
2011 ND

20
<10

<10
20

ND
ND

80 <10 YFV positive
<20 160 RVFV antibody positive; flavivirus nonspecific
<10 10 flavivirus non-specific; RVFV negative
20 <40 flavivirus non-specific

2012 <40

<40

80

<40

80

<40 flavivirus non-specific

2012 <10
2012 <10

10
<10

10
10

<10
<10

20
20

<10 flavivirus non-specific
<10 flavivirus non-specific

result was determined, and five representative bats
for which serological results were inconclusive based
on our criteria.
A total of 2/432 (0.5%) bats contained specific
neutralizing antibodies against BBKV: one Egyptian
rousette bat and one little epauletted fruit bat (Tables
2 and 3). Nine of the 303 (3%) Egyptian rousette bats
tested from Maramagambo forest exhibited alphavirus neutralizing antibodies, but could not be confirmed as BBKV (Table 2). Five of 52 (9.6%) little
epauletted fruit bats from Kawuku and 3/54 (5.6%)
Egyptian rousette bats from Kasokero cave contained
specific neutralizing antibodies against RVFV.

Discussion
Overall, exposure of fruit and insectivorous bat species to flaviviruses was widespread, although prevalence in any one species was often low, suggesting
possible incidental exposure (Table 2). This common
detection of flavivirus antibodies is consistent with
previous studies [6–8]. In particular, 23/86 (27%)
little free-tailed bats, spanning every collection during
the study period, demonstrated neutralizing antibodies against flaviviruses (Table 2). We were unfortunately not able to distinguish among the flavivirus
infections in the majority of cases, despite using the
most specific antibody assay, the PRNT. It is unclear
whether these ambiguous results are the result of an
infection(s) with one or more of the flaviviruses
included in our panel, or with a different flavivirus
altogether. Flaviviruses including Entebbe bat virus
(ENTV)[5,16], Bukalasa bat virus (BBV) and Dakar
bat virus (DBV)[6,8], have been previously isolated
from little free-tailed and Angolan free-tailed bats in
Uganda, leaving open the possibility that some of the
flavivirus antibody-positive bats in this study had
been infected with one of those other viruses. We
did not assess the serological cross-reactivity between
ENTV, BBV, or DBV with the mosquito-borne

<10 WNV positive

viruses in our panel because they are classified in
different antigenic complexes within the family
Flaviviridae and therefore unlikely to cross-react serologically [17]. Egyptian rousette bats also displayed a
relatively high flavivirus seroprevalence across all collections, with a total of 53/402 (13%) of Egyptian
rousette bats exhibiting flavivirus neutralizing antibodies. Aside from one bat captured at Tutum cave
which was considered to be antibody-positive for
YFV, we did not generate any convincing evidence
indicating which flavivirus was the infecting virus in
any other Egyptian rousette bat sampled. Follow-up
testing of the liver/spleen homogenates from these
seropositive Egyptian rousette bats using pan-flavivirus primers [15] did not result in any positive
amplifications (Kading, unpublished data). The tissues from one little free-tailed bat from 2011 which
yielded an isolate of ENTV, were flavivirus RNApositive [16]. Development of specific assays targeting
sub-genomic flaviviral RNA (sfRNA), which can be
present in high amounts in infected cells, may be one
approach to deciphering ambiguous serological
results in future investigations [18,19].
Among the alphaviruses, a variant of Sindbis virus,
BBKV, is known to cause fever and arthralgia in
humans and has been isolated from numerous mosquito species across Africa, including Cx. (Cx.) decens
group and Cx. (Cx.) perfuscus Edwards [20,21]. In
this study, two bats were seropositive for BBKV:
one little epauletted fruit bat from Kikaaya, and one
Egyptian rousette bat from Kasokero cave.
Mosquitoes collected in Uganda that were documented to have engorged on fruit bats included Cx. perfuscus on straw-colored fruit bats and Egyptian
rousette bats in Semliki Forest, Cx. (Cx.) neavei
Theobald on Egyptian rousette bats in Semliki
Forest and Maramagambo forest, and Cx decens
group mosquitoes on Egyptian rousette bats in
Maramagambo forest [11]. Further, several isolates
of BBKV were obtained from Cx. perfuscus collected
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from multiple locations in Uganda during this same
sampling period [21]. Among the 40 blood meals
previously identified from Cx. perfuscus in Uganda
[11], 90% were taken from mammalian hosts, and
10% from avian hosts comprising at least 11 different
species [11]. The majority of mammalian blood meals
(26/36; 72%) came from ungulates, however, blood
meals from bats comprised 7.5% of the total blood
meals identified from this mosquito species [11].
Whether bats contribute to the transmission cycle of
BBKV or are merely incidentally exposed through
being fed upon by mosquitoes is unclear.
The involvement of a wild mammal reservoir in
the epidemiologic cycle of RVFV is also unknown.
Olive et al. [22] reviewed what is currently known
about the role of wild mammals in the maintenance
of RVFV. As with many vertebrate taxa, the potential
involvement of bats in the interepidemic maintenance of RVFV has not been thoroughly investigated.
Available experimental data suggest that RVFV is
capable of replication in bats, and that infection
could be asymptomatic [22]. Experimental inoculation of Schreiber’s long-fingered bats (Miniopterus
schreibersii) and Cape serotines (Eptesicus capensis)
confirmed that these bats were capable of becoming
infected with RVFV without showing signs of clinical
illness [22,23]. Further, RVFV has been previously
isolated from several bat species including Peters’
lesser epauletted fruit bat (Micropteropus pusillus),
the Aba leaf-nosed bat (Hipposideros abae) and
Sundevall’s leaf-nosed bat (Hipposideros caffer),
Franquet’s epauletted fruit bat (Epomops franqueti),
and the common butterfly bat (Glauconycteris argentata) [24–26], demonstrating that bats are naturally
exposed to this virus.
RVFV is endemic to Uganda, characterized by low
levels of enzootic activity as opposed to the large-scale
epidemics experienced by neighboring East African
countries [27]. RVFV has been previously isolated
from mosquitoes captured on the Entebbe peninsula
[28], and a localized outbreak in the Kabale district of
Western Uganda in 2016 confirms recent RVFV circulation [29]. In this study, bats from two collections
contained several individuals with neutralizing antibodies against RVFV. These collections comprised 3/54
(5.5%) Egyptian rousette bats from Kasokero cave
captured in 2013, and 5/52 (9.6%) little epauletted
fruit bats from Kawuku, also from 2013. Kasokero
cave and Kawuku are both located on the shore of
Lake Victoria, and are approximately 80 km apart
(Figure 1). In addition to the bats considered seropositive with an antibody titer of PRNT80 ≥ 20, there
were several additional little epauletted fruit bats from
Kikaaya (2011) and Buwaya Lugonjo (2011–2012), and
one Egyptian rousette bat from Tutum cave (2012)
with antibody titers of PRNT80 = 10 for RVFV that
were considered inconclusive. If these additional
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results are indicative of a true infection with RVFV,
these observations collectively suggest that exposure of
fruit bats in Uganda to RVFV is fairly widespread
(Kasokero cave to Tutum cave is >200km). However,
it is also possible that at least some of these results are
attributable to circulation of a different, unidentified,
phlebovirus. Mourya et al. [30] reported a novel bat
phlebovirus named Malsoor virus, related to severe
fever with thrombocytopenia syndrome virus
(SFTSV). Malsoor virus was isolated from a related
fruit bat (Rousettus leschenaultia) in Western India
[30]. Mossel et al. [21] reported two isolations of
Arumowot virus (Phenuiviridae, Phlebovirus) from
Culex mosquitoes collected in Jinja, Uganda, in 2012.
While Malsoor and Arumowot viruses are both distantly related to RVFV [30], we did not evaluate the
potential for cross-reactivity of these samples to other
phleboviruses. The ability of Egyptian rousette bats
and little epauletted fruit bats to become infected
with RVFV and develop viremias high enough to
infect feeding mosquitoes is unknown.
An important aspect to the ecology of arbovirus
transmission that was not addressed in this study is
the influence of geographic location and land-use/
land cover on the prevalence of arbovirus antibodies
in bats. The bat species captured in this study are all
widely distributed in Uganda, but tend to occupy
particular habitats such as man-made structures,
caves, or tall trees. The agro-ecological conditions
associated with the bat collection locations would
also influence the presence and abundance of mosquito vectors through the availability of suitable larval
habitats and preferred hosts. The co-occurrence of
vector, host, and virus with landscape and environmental conditions is important to the emergence and
circulation of arboviruses. Bat migration and dispersal patterns also make it difficult to know where they
would have become infected. Future investigations
should include modelling component to evaluate the
co-incidence of vector and host distribution and
pathogen detection data in an ecological context.
In conclusion, this study provides novel data on the
exposure of multiple species of fruit and insectivorous
bats in Uganda to a variety of arboviruses. While the role
of bats in arbovirus transmission cycles is still unfolding,
we have built upon previous studies [6,8,11,21] to
demonstrate ecological associations between bats, arboviruses, and mosquito vectors in Uganda. This study
provides additional field evidence of mosquito-bat contact through the detection of neutralizing antibodies in
bat populations against arboviruses which were contemporaneously isolated from mosquitoes in Uganda (i.e.
WNV, BBKV)[21]. To further define and quantify the
contribution of bats to arbovirus transmission cycles,
more data are needed on the contact rates between different species of bats with mosquito vectors, as well as the
competency of these bat species as amplification hosts for
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specific viruses [31]. In particular, experimental studies
are needed to evaluate the ability of Egyptian rousette bats
and little epauletted fruit bats to support replication of
BBKV and RVFV and develop viremias high enough to
infect feeding mosquitoes. These experimental data
would provide important insight into the epidemiological
significance and interpretation of the serological data
presented in this study.
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